SCHEMBL7455253

SCHEMBL7455253

Cc1ccc(S(=O)(=O)NC(=S)Nc2ccccn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.58
KDM4E B2RXH2 5/20 0.55
MAPT P10636 4/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
LMNA P02545 3/20 0.55
HTT P42858 2/20 0.55
GAA P10253 2/20 0.55
GFER P55789 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ALDH1A1 P00352 6/20 0.55
RAB9A P51151 5/20 0.53
NPC1 O15118 3/20 0.53
ALOX12 P18054 1/20 0.53
NPSR1 Q6W5P4 3/20 0.53
KMT2A Q03164 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PPARG P37231 1/20 0.50
KCNH2 Q12809 1/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7459723 0.79 KDM4E (0.56) PTGS2KDM4ELMNAGAAALDH1A1
SCHEMBL7454603 0.79 KDM4E (0.56) PTGS2KDM4EMAPTLMNAGAA
SCHEMBL5186788 0.79 ALDH1A1 (0.74) KDM4EMAPTSMN1; SMN2LMNAGAA
SCHEMBL15215659 0.78 POLB (0.72) KDM4EMAPTSMN1; SMN2LMNAHTT
SCHEMBL7459393 0.77 MAPK8 (0.53) PTGS2KDM4EMAPTGAAALDH1A1
SCHEMBL11173864 0.77 RAB9A (0.75) KDM4EMAPTSMN1; SMN2LMNAHTT
SCHEMBL7454826 0.76 PTGS2 (0.58) PTGS2KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL7297544 0.76 ALDH1A1 (0.52) PTGS2KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL8489624 0.75 NAMPT (0.60) PTGS2KDM4EMAPTALDH1A1RAB9A
SCHEMBL10934987 0.74 ALDH1A1 (0.50) KDM4EMAPTSMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819118-B1 POTASSIUM ION CHANNEL BLOCKERS POLYCHIP PHARMACEUTICALS PTY (AU) 2002-09-18 EP disclosed
US-5929082-A SULFONYL(THIO)UREA AND SULFONYLGUANIDINE COMPOUNDS; TREATMENT OF DIABETES, CARDIAC ARRHYTHMIAS, ISCHEMIA, HYPOXIC CARDIOVASCUALR DISORDERS AND CANCER POLYCHIP PHARMACEUTICALS PTY LTD (AU) 1999-07-27 US disclosed
EP-0819118-A4 POTASSIUM ION CHANNEL BLOCKERS POLYCHIP PHARMACEUTICALS PTY (AU) 1998-04-29 EP disclosed
EP-0819118-A1 POTASSIUM ION CHANNEL BLOCKERS Polychip Pharmaceuticals Pty. Ltd. (AU) 1998-01-21 EP disclosed
WO-1996030341-A1 POTASSIUM ION CHANNEL BLOCKERS POLYCHIP PHARMACEUTICALS PTY. LTD. (AU) 1996-10-03 WO disclosed